Baillie Gifford - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 39 filers reported holding SUMMIT THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$1,070,000
-8.9%
436,5120.0%0.00%0.0%
Q4 2021$1,174,000
-46.3%
436,5120.0%0.00%0.0%
Q3 2021$2,187,000
-32.8%
436,5120.0%0.00%
-50.0%
Q2 2021$3,256,000
+49.0%
436,512
+17.3%
0.00%
+100.0%
Q1 2021$2,185,000
+24.9%
372,2610.0%0.00%0.0%
Q4 2020$1,749,000
+36.5%
372,2610.0%0.00%0.0%
Q3 2020$1,281,000372,2610.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 50,714$94,8350.06%
Baker Brothers Advisors 3,140,473$5,872,6850.03%
VANCE WEALTH, INC. 39,266$73,4270.03%
CSS LLC/IL 258,814$483,9820.03%
SHELL ASSET MANAGEMENT CO 317,240$5930.02%
Steward Partners Investment Advisory, LLC 650,000$1,215,5000.02%
Alpine Global Management, LLC 30,000$56,1000.01%
HoyleCohen, LLC 74,408$139,1430.01%
BENDER ROBERT & ASSOCIATES 24,059$44,9900.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 86,212$161,2160.01%
View complete list of SUMMIT THERAPEUTICS INC shareholders